Multiplexed LC–ESI–MRM‐MS‐based Assay for Identification of Coronary Artery Disease Biomarkers in Human Plasma

A highly‐multiplexed LC–ESI–multiple reaction monitoring‐MS‐based assay is developed for the identification of coronary artery disease (CAD) biomarkers in human plasma.

[1]  W. Kannel,et al.  Natural history of angina pectoris in the Framingham study. Prognosis and survival. , 1972, The American journal of cardiology.

[2]  R. Cooks,et al.  Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures , 1978 .

[3]  J. Travis,et al.  The reactive site of human alpha 2-antiplasmin. , 1987, The Journal of biological chemistry.

[4]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[5]  J. Griffin,et al.  Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. , 1993, The Journal of biological chemistry.

[6]  M. Wojtukiewicz,et al.  von Willebrand factor antigen and fibronectin in essential hypertension. , 1995, Thrombosis research.

[7]  J. Griffin,et al.  C-terminal Residues 621–635 of Protein S Are Essential for Binding to Factor Va* , 1999, The Journal of Biological Chemistry.

[8]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[9]  A. Siegbahn,et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.

[10]  A. Maseri,et al.  Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease: Predictive Role of C-Reactive Protein , 2002, Circulation.

[11]  A. Maseri,et al.  Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease , 2002 .

[12]  E Vuori,et al.  Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[14]  W. Gross,et al.  Distribution spectrum of paraoxonase activity in HDL fractions. , 2004, Clinical chemistry.

[15]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[16]  Leigh Anderson,et al.  Candidate‐based proteomics in the search for biomarkers of cardiovascular disease , 2005, The Journal of physiology.

[17]  K. Hajjar,et al.  Molecular mechanisms of fibrinolysis , 2005, British journal of haematology.

[18]  P. Libby,et al.  Pathophysiology of Coronary Artery Disease , 2005, Circulation.

[19]  K. Walley,et al.  Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort , 2006, Canadian Medical Association Journal.

[20]  A. Spitzer,et al.  Mass Spectrometry in Neonatal Medicine and Clinical Diagnostics—the Potential Use of Mass Spectrometry in Neonatal Brian Monitoring , 2006 .

[21]  A. Spitzer,et al.  Mass spectrometry in neonatal medicine and clinical diagnosis--the [corrected] potential use of mass spectrometry in neonatal brain [corrected] monitoring. , 2006, Clinics in perinatology.

[22]  L. Lipsitt,et al.  Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: Still valid after all these years , 2007, Psychoneuroendocrinology.

[23]  G. Gamba,et al.  Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease , 1985, Acta diabetologia latina.

[24]  J. L. López,et al.  A better understanding of molecular mechanisms underlying human disease , 2007, Proteomics. Clinical applications.

[25]  A. Engler,et al.  Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. , 2008, Cancer research.

[26]  Zhihe Liu,et al.  Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell Death* , 2008, Journal of Biological Chemistry.

[27]  T. Hackeng,et al.  Regulation of coagulation by protein S , 2008, Current opinion in hematology.

[28]  Christoph H Borchers,et al.  Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.

[29]  Christopher P Cannon,et al.  Acute coronary syndromes: diagnosis and management, part I. , 2009, Mayo Clinic proceedings.

[30]  T. Grimsrud,et al.  Stability of selected serum proteins after long-term storage in the Janus Serum Bank , 2009, Clinical chemistry and laboratory medicine.

[31]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[32]  R. Aebersold,et al.  Increased Selectivity, Analytical Precision, and Throughput in Targeted Proteomics , 2010, Molecular & Cellular Proteomics.

[33]  John S. Hill,et al.  Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. , 2010, Journal of the American College of Cardiology.

[34]  Galit Shmueli,et al.  To Explain or To Predict? , 2010, 1101.0891.

[35]  N. Anthonisen,et al.  Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. , 2011, European heart journal.

[36]  John S. Hill,et al.  Combined Polymorphisms in Oxidative Stress Genes Predict Coronary Artery Disease and Oxidative Stress in Coronary Angiography Patients , 2012, Annals of human genetics.

[37]  Raymond T. Ng,et al.  A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers , 2012, BMC Bioinformatics.

[38]  E. Jansen,et al.  Long term stability of paraoxonase-1 and high-density lipoprotein in human serum , 2012, Lipids in Health and Disease.

[39]  Juncong Yang,et al.  MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.

[40]  M. Garelnabi,et al.  Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases , 2012, North American journal of medical sciences.

[41]  Jirí Jarkovský,et al.  [Inflammatory response and C -reactive protein value in patient with acute coronary syndrome]. , 2013, Vnitrni lekarstvi.

[42]  D. Girelli,et al.  Paraoxonases: ancient substrate hunters and their evolving role in ischemic heart disease. , 2013, Advances in clinical chemistry.

[43]  Raymond T. Ng,et al.  Computational Biomarker Pipeline from Discovery to Clinical Implementation: Plasma Proteomic Biomarkers for Cardiac Transplantation , 2013, PLoS Comput. Biol..

[44]  T. van der Poll,et al.  Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). , 2013, American journal of respiratory and critical care medicine.

[45]  T. Funahashi,et al.  Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio. , 2013, Metabolism: clinical and experimental.

[46]  J. Wen,et al.  ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method , 2013, Evidence-based complementary and alternative medicine : eCAM.

[47]  Y. Zhang,et al.  Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients , 2014, BioMed research international.

[48]  C. Rotimi,et al.  High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum. , 2014, Clinical biochemistry.

[49]  F. Borràs,et al.  Human scavenger protein AIM increases foam cell formation and CD36‐mediated oxLDL uptake , 2014, Journal of leukocyte biology.

[50]  K. Sutton-Tyrrell,et al.  Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[51]  N. Bogavac-Stanojević,et al.  Factor analysis of risk variables associated with iron status in patients with coronary artery disease. , 2014, Clinical biochemistry.

[52]  W. März,et al.  Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study). , 2014, Atherosclerosis.

[53]  Xi-Long Zheng,et al.  Lipoprotein lipase: from gene to atherosclerosis. , 2014, Atherosclerosis.

[54]  B. McManus,et al.  Proteomic biomarkers of recovered heart function , 2014, European journal of heart failure.

[55]  P. D. de Groot,et al.  Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network* , 2014, The Journal of Biological Chemistry.

[56]  Maya Petersen,et al.  Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates. , 2015, Electronic journal of statistics.

[57]  K. Matthews,et al.  Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study. , 2015, Atherosclerosis.

[58]  P. Serruys,et al.  Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome , 2015, Thrombosis and Haemostasis.

[59]  R. Simó,et al.  Novel insights in SHBG regulation and clinical implications , 2015, Trends in Endocrinology & Metabolism.

[60]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[61]  A. Gedikbaşı,et al.  Serum paraoxonase 1 activity in patients with iron deficiency anemia , 2016, Archives of medical science : AMS.

[62]  D. Siscovick,et al.  Associations of cortisol/testosterone and cortisol/sex hormone-binding globulin ratios with atherosclerosis in middle-age women , 2016, Atherosclerosis.

[63]  A. Sangamwar,et al.  Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192 , 2016, PloS one.

[64]  S. Rivière,et al.  Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia. , 2016, Archivos de cardiologia de Mexico.

[65]  Gareth Ambler,et al.  Review and evaluation of penalised regression methods for risk prediction in low‐dimensional data with few events , 2015, Statistics in medicine.

[66]  C. Tovilla-Zárate,et al.  Effects of paraoxonase 1 gene polymorphisms on heart diseases , 2016, Medicine.

[67]  E. Martínez-Quintana,et al.  Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event. , 2017, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[68]  C. Minelli,et al.  The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[69]  G. Watts,et al.  Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia. , 2017, Journal of clinical lipidology.